Optic Neuropathy Secondary to Linezolid for Multidrug-resistant Mycobacterial Tuberculosis

ARSI NOVIANA SARI, Ika Nuraita
{"title":"Optic Neuropathy Secondary to Linezolid for Multidrug-resistant Mycobacterial Tuberculosis","authors":"ARSI NOVIANA SARI, Ika Nuraita","doi":"10.35749/gs8mrs86","DOIUrl":null,"url":null,"abstract":"Abstract \nIntroduction : Toxic optic neuropathy is well known side effect of medications, including linezolid in patients with MDR-TB. We present 2 cases of patients with linezolid associated ON. \nCase Illustration : A 28 year pld man (case 1) and a 50 year old woman complained bilateral progressive visual loss after long term use of linezolid (both 8 months). On initial visit, case 1 presented with 0.1 visual acuity and case 2 presented with counting finger visual acuity. Both have hyperemic optic disc. OCT showed optic disc edema. Both patients showed generalized visual field defect on the Humphrey test. We immediately stopped the linezolid treatment. \nDiscussion : The exact mechanism of linezolid induced ON is still unclear. It may be caused by impaired mitochondrial function for adenosine triphosphate (ATP) synthesis within retinal nerve fiber layer. Duration of linezolid therapy affects the prognosis for linezolid ON. \nConclusion : Both Ophthalmologist and Physicians must be aware that visual function monitoring and early recognition of toxicity linezolid. Immediate cessation of linezolid has favorable visual recovery","PeriodicalId":165753,"journal":{"name":"Ophthalmologica Indonesiana","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmologica Indonesiana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35749/gs8mrs86","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract Introduction : Toxic optic neuropathy is well known side effect of medications, including linezolid in patients with MDR-TB. We present 2 cases of patients with linezolid associated ON. Case Illustration : A 28 year pld man (case 1) and a 50 year old woman complained bilateral progressive visual loss after long term use of linezolid (both 8 months). On initial visit, case 1 presented with 0.1 visual acuity and case 2 presented with counting finger visual acuity. Both have hyperemic optic disc. OCT showed optic disc edema. Both patients showed generalized visual field defect on the Humphrey test. We immediately stopped the linezolid treatment. Discussion : The exact mechanism of linezolid induced ON is still unclear. It may be caused by impaired mitochondrial function for adenosine triphosphate (ATP) synthesis within retinal nerve fiber layer. Duration of linezolid therapy affects the prognosis for linezolid ON. Conclusion : Both Ophthalmologist and Physicians must be aware that visual function monitoring and early recognition of toxicity linezolid. Immediate cessation of linezolid has favorable visual recovery
利奈唑胺治疗耐多药分枝杆菌肺结核继发视神经病变
摘要 简介:中毒性视神经病变是众所周知的药物副作用,包括利奈唑胺对MDR-TB患者的副作用。我们报告了两例利奈唑胺相关性视神经病变患者。病例说明:一名28岁的男性患者(病例1)和一名50岁的女性患者在长期服用利奈唑胺(均为8个月)后出现双侧进行性视力下降。初诊时,病例 1 的视力为 0.1,病例 2 的视力为数指。两人的视盘都充血。OCT 显示视盘水肿。在汉弗莱测试中,两名患者均表现为全身视野缺损。我们立即停止了利奈唑胺的治疗。讨论:利奈唑胺诱发ON的确切机制尚不清楚。它可能是由于线粒体在视网膜神经纤维层内合成三磷酸腺苷(ATP)的功能受损所致。利奈唑胺治疗的持续时间会影响利奈唑胺ON的预后。结论:眼科医生和内科医生必须意识到视觉功能的监测和利奈唑胺毒性的早期识别。立即停止利奈唑胺治疗有利于视力恢复
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信